Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Evaluate the Effect of BKR-013 on Average Daily Glucose Levels in Type 2 Diabetes Patients
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Glutamine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors BioKier
- 31 Jan 2018 Status changed from not yet recruiting to recruiting.
- 18 Dec 2017 Status changed from planning to not yet recruiting.
- 26 May 2016 New trial record